What is it?
A rare disease found in humans also known as Kanzaki disease and/or alpha-N-acetylgalactosaminidase deficiency.
There are three main types of the disease each with its own distinctive symptoms.[4]
- Type I infantile form, infants will develop normally until about a year old. At this time, the affected infant will begin to lose previously acquired skills involving the coordination of physical and mental behaviors. Additional neurological and neuromuscular symptoms such as diminished muscle tone, weakness, involuntary rapid eye movements, vision loss, and seizures may become present. With time, the symptoms worsen and children affected with this disorder will experience a decreased ability to move certain muscles due to muscle rigidity. The ability to respond to external stimuli will also decrease. Other symptoms include neuroaxonal dystrophy from birth, discoloration of skin, Telangiectasia or widening of blood vessels.
- Type II adult form, symptoms are milder and may not appear until the individual is in his or her 30s. Angiokeratomas, an increased coarsening of facial features, and mild intellectual impairment are likely symptoms.
- Type III is considered an intermediate disorder. Symptoms vary and can include to be more severe with seizures and mental retardation, or less severe with delayed speech, a mild autistic like presentation, and/or behavioural problems.
Complications /Information to beware of/General tips:
Please talk to your healthcare professional (i.e. Medical Doctor/Pharmacist) for further advice
Detailed Information
Please copy and paste any key words from the title: Schindler Disease in the following respective 'Medtick References and/or Sources' to find out more about the disease (this also may include diagnosis tests and generic medical treatments).
- Medical News Today
Medical news and health news headlines posted throughout the day, every day.
- Medscape (Professional level)
Latest medical news and expert commentary in your specialty as well as disease information.
- Healthline
Medical Information and health advice you can trust
- EveryDay Health
Wellness inspired. Wellness enabled.
- Pharmaceutical Journal (Professional level)
The Pharmaceutical Journal covers analysis, features, opinion, learning and careers articles, providing insight and knowledge about drugs, pharmacy practice, medicines use and healthcare policy in the context of the pharmacy profession and pharmaceutical science.
- NHS
Find information and advice on health conditions, symptoms, healthy living, medicines and how to get help (British National Health Service).
- WebMD
Better Information. Better Health.
- Cleveland Clinic
Pushing the Standards of care.
- Mayo Clinic
No.1 Hospital in the Nation (America)
- Drugs.com
Know more. Be sure.
- National Organisation of Rare Diseases
NORD is dedicated to supporting education, elevating care, advancing research, and driving policy for rare diseases.
- Verywell Health
Know more. Fell better.
- Fit for Travel
Information on how to stay safe and healthy abroad.
- DR Axe
Health and fitness news. Recipes, Natural Remedies
- ChatGPT (The answers here can't be verified, as it may finds answers from not the above sources)
Get instant answers, find creative inspiration, and learn something new.
- DeepSeek (The answers here can't be verified, as it may finds answers from not the above sources)
Into the unknown.
References
- Wang AM, Schindler D, Desnick R (November 1990). “Schindler disease: the molecular lesion in the alpha-N-acetylgalactosaminidase gene that causes an infantile neuroaxonal dystrophy”. J. Clin. Invest. 86 (5): 1752–6. PMC 296929 . PMID 2243144. doi:10.1172/JCI114901.
- Online Mendelian Inheritance in Man (OMIM) 609241
- Cantz M, Ulrich-Bott B (1990). “Disorders of glycoprotein degradation”. J. Inherit. Metab. Dis. 13 (4): 523–37. PMID 2122119. doi:10.1007/BF01799510.
- “Schindler disease”. International Advocate for Glycoprotein Storage Diseases. (International Society for Mannosidosis & Related Diseases, ISMRD). Retrieved 2008-11-13.
- “Schindler Disease”. National Organization for Rare Disorders (NORD). Retrieved 2008-11-13.
wikipedia.org
